High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C

David N Moskovitz; Pooma Manoharan; E Jenny Heathcote

doi:10.1155/2003/131943

Canadian Journal of Gastroenterology (Jan 2003)

High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C

David N Moskovitz,
Pooma Manoharan,
E Jenny Heathcote

Affiliations

David N Moskovitz: Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Pooma Manoharan: Department of Medicine, University of Toronto, Toronto, Ontario, Canada
E Jenny Heathcote: Department of Medicine, University of Toronto, Toronto, Ontario, Canada

DOI: https://doi.org/10.1155/2003/131943
Journal volume & issue: Vol. 17, no. 8
pp. 479 – 482

Abstract

Read online

OBJECTIVES: Approximately 60% of patients with chronic hepatitis C treated with a combination of interferon (IFN) alpha-2b and ribavirin are nonresponders. The purpose of the present study was to evaluate the efficacy of treatment with high dose consensus IFN (CIFN) (15 µg/day) in nonresponders.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal